Last edition
News about
India's drug regulator to ease oversight and deploy AI for greater efficiency
India’s drug regulator, the Central Drugs Standard Control Organisation (CDSCO), is preparing to introduce fixed timelines for drug approvals and increase the use of artificial intelligence to strengthen efficiency and transparency.
Arrowhead and Novartis Sign Global License and Collaboration Deal
Novartis secures exclusive global rights to Arrowhead’s ARO-SNCA therapy for Parkinson’s and related disorders, with Arrowhead receiving USD 200 million upfront.
Granules India and NIPER SAS Nagar Open Centre for Sustainable Pharma Solutions
Granules India and NIPER collaborate to open the Dr Chigurupati Centre of Excellence for empowering researchers with advanced facilities towards eco-friendly pharmaceutical manufacturing.
Gilead breaks ground on new manufacturing hub as part of USD 32 billion US investment plan
Gilead Sciences has begun construction of a new Pharmaceutical Development and Manufacturing hub at its headquarters in Foster City, California, as part of a USD 32 billion investment programme to expand its manufacturing capabilities in the United States.
Argo Biopharma and Novartis Partner on Novel Cardiovascular Therapies
Argo to receive $160 million upfront as Novartis licenses pipeline assets, explores ANGPTL3 in dyslipidemia, and secures options for future siRNA candidates.
Syantra, Inc., a cancer diagnostics innovator, has launched a new therapeutic division aimed at developing first-in-class immuno-oncology therapies to reprogram tumour-affected immune cells and restore anti-cancer immunity.
ICMR Licenses Nine Health Tech Innovations at India MedTech Expo 2025
At the India MedTech Expo 2025 in Delhi, ICMR licensed nine breakthrough technologies to industry partners under its Patent Mitra initiative, sealing 17 deals in diagnostics and vaccine development to advance affordable, homegrown healthcare.
Zydus and Synthon Sign Exclusive Licensing and Supply Agreement for Ozanimod Capsules for US Market
Zydus Lifesciences’ subsidiary Zydus Lifesciences Global FZE has signed an exclusive licensing and supply deal with Synthon BV to commercialise generic Ozanimod Capsules (ZEPOSIA) in the US market.
DPIIT, Pfizer Ink Partnership to Support MedTech Startups
The Pfizer INDovation programme will empower DPIIT-recognised startups with grants of up to INR 60 lakhs each, along with a tailored 18-month incubation programme delivered by Social Alpha.
<br />
GST Reforms Hailed as 'a Decisive Win for Patients and Pharma Players'
Indian drug and medical device manufacturers have welcomed the GST reduction on medical devices and lifesaving drugs, calling it a major step toward improving access and easing treatment costs.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy